Antinociceptive effects of venlafaxine in a rat model of peripheral neuropathy: Role of alpha2-adrenergic receptors

European Journal of Pharmacology

Volumn 738, Issue , 2014, Pages 230-236

  Hajhashemi, Valiollah ^a   Banafshe, Hamid Reza ^b   Minaiyan, Mohsen ^a   Mesdaghinia, Azam ^b   Abed, Alireza ^c  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Chronic constriction injury; Neuropathic pain; Venlafaxine; Yohimbine

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; VENLAFAXINE; YOHIMBINE; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ANALGESIC AGENT; CYCLOHEXANOL DERIVATIVE;

ALLODYNIA; ANALGESIC ACTIVITY; ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; COLD SENSITIVITY; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFICACY; DRUG SAFETY; HYPERALGESIA; MALE; NEUROPATHIC PAIN; NONHUMAN; PAIN THRESHOLD; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; RAT; SCIATIC NERVE INJURY; ANIMAL; ANIMAL BEHAVIOR; DRUG EFFECTS; METABOLISM; NEURALGIA; SPRAGUE DAWLEY RAT;

ADRENERGIC ALPHA-2 RECEPTOR ANTAGONISTS; ANALGESICS; ANIMALS; BEHAVIOR, ANIMAL; CYCLOHEXANOLS; HYPERALGESIA; MALE; NEURALGIA; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-2; YOHIMBINE;

EID: 84902707592     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2014.04.046     Document Type: Article

References (36)

1. B. Amin, V. Hajhashemi, H. Hosseinzadeh, and K. Abnous Antinociceptive evaluation of ceftriaxone and minocycline alone and in combination in a neuropathic pain model in rat Neuroscience 224 2012 15 25
2. R.J. Baldessarini Drugs for the treatment of psychiatric disorders J.G. Hardman, L.E. Limbird, A. Goodman Gilman, Goodman & Gilman's The Pharmacological Basis of Therapeutics 10th ed. 2001 McGraw Hill New York, USA 447 483
3. H.R. Banafshe, G.A. Hamidi, M. Noureddini, M. Mirhashemi, R. Mokhtari, and M. Shoferpour Effect of curcumin on diabetic peripheral neuropathic pain: Possible involvement of opioid system Eur. J. Pharmacol. 723 2014 202 206
4. H.R. Banafshe, A. Mesdaghinia, M.N. Arani, M.H. Ramezani, A. Heydari, and G.A. Hamidi Lithium attenuates pain-related behavior in a rat model of neuropathic pain: possible involvement of opioid system Pharmacol. Biochem. Behav. 100 3 2012 425 430
5. G.J. Bennett, and Y.K. Xie A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man Pain 33 1988 87 107
6. 1Areceptors J. Pharmacol. Exp. Ther. 322 1 2007 101 107
7. D.D. Cardenas, C.A. Warms, J.A. Turner, H. Marshall, M.M. Brooke, and J.D. Loeser Efficacy of amitriptyline for relief of pain in spinal cord injury: results of a randomized controlled trial Pain 96 3 2002 365 373
8. K. Cegielska-Perun, M. Bujalska-Zadrozny, J. Tatarkiewicz, E. Ga̧sińska, H. Elzbieta, and M. Nowak Venlafaxine and neuropathic pain Pharmacology 91 2013 69 76
9. Y. Choi, Y.W. Yoon, H.S. Na, S.H. Kim, and J.M. Chung Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain Pain 59 1994 369 376
10. L.J. Dableh, and J.L. Henry Progesterone prevents development of neuropathic pain in a rat model: Timing and duration of treatment are critical J. Pain Res. 4 2011 91 101
11. A.E. Dubin, and A. Patapoutian Nociceptors: the sensors of the pain pathway J. Clin. Invest. 120 11 2010 3760 3772
12. J.P. Durand, G. Deplanque, V. Montheil, J.M. Gornet, F. Scotte, and O. Mir et al. Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial Ann. Oncol. 23 2012 200 205
13. M.M. Dwight, L.M. Arnold, H. O'Brien, R. Metzger, E. Morris-Park, and P.E. Keck An open clinical trial of venlafaxine treatment of fibromyalgia Psychosomatics 39 1998 14 17
14. T.M. Egan, G. Henderson, R.A. North, and J.T. Williams Noradrenaline-mediated synaptic inhibition in rat locus coeruleus neurones J. Physiol. 345 1983 477 488
15. V.L. Ellingrod, and P.J. Perry Venlafaxine: a heterocyclic antidepressant Am. J. Hosp. Pharm. 51 1994 3000 3046
16. J. Guindon, and A.G. Hohmann Recent advances in the pharmacological management of pain Drugs 67 2007 2121 2133
17. V. Hajhashemi, H. Sadeghi, M. Minaiyan, A. Movahedian, and A. Talebi Central and peripheral anti-inflammatory effects of maprotiline on carrageenan-induced paw edema in rats Inflamm. Res. 59 12 2010 1053 1059
18. G.A. Hamidi, M.H. Ramezani, M.N. Arani, S.A. Talaei, A. Mesdaghinia, and H.R. Banafshe Ethosuximide reduces allodynia and hyperalgesia and potentiates morphine effects in the chronic constriction injury model of neuropathic pain Eur. J. Pharmacol. 674 2-3 2012 260 264
19. T.S. Jensen, H. Gottrup, S.H. Sindrup, and F.W. Bach The clinical picture of neuropathic pain Eur. J. Pharmacol. 429 2001 1 11
20. Y. Kawasaki, E. Kumamoto, H. Furue, and M. Yoshimura Alpha 2 adrenoceptor-mediated presynaptic inhibition of primary afferent glutamatergic transmission in rat substantia gelatinosa neurons Anesthesiology 98 2003 682 689
21. S. Koch, S.K. Hemrick-Luecke, L.K. Thompson, D.C. Evans, P.G. Threlkeld, and D.L. Nelson et al. Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats Neuropharmacology 45 2003 935 944
22. W.S. Kingery, G.S. Agashe, T.Z. Guo, S. Sawamura, M.F. Davies, and J.D. Clark et al. Isoflurane and nociception: spinal alpha2A adrenoceptors mediate antinociception while supraspinal alpha1 adrenoceptors mediate pronociception Anesthesiology 96 2002 367 374
23. P.M. Lavand'homme, and J.C. Eisenach Perioperative administration of the alpha2-adrenoceptor agonist clonidine at the site of nerve injury reduces the development of mechanical hypersensitivity and modulates local cytokine expression Pain 105 2003 247 254
24. M. Malcangio, and D.R. Tomlinson A pharmacologic analysis of mechanical hyperalgesia in streptozotocin/diabetic rats Pain 76 1998 151 157
25. F. Marchand, A. Alloui, E. Chapuy, A. Hernandez, T. Pelissier, D. Ardid, and A. Eschalier The antihyperalgesic effect of venlafaxine in diabetic rats does not involve the opioid system Neurosci. Lett. 342 1-2 2003 105 108
26. F. Marchand, A. Alloui, E. Chapuy, D. Jourdan, T. Pelissier, D. Ardid, A. Hernandez, and A. Eschalier Evidence for a monoamine mediated, opioid-independent, antihyperalgesic effect of venlafaxine, a non-tricyclic antidepressant, in a neurogenic painmodel in rats Pain 103 2003 229 235
27. X. Paqueron, D. Conklin, and J.C. Eisenach Plasticity in action of intrathecal clonidine to mechanical but not thermal nociception after peripheral nerve injury Anesthesiology 99 2003 199 204
28. L.H. Pedersen, A.N. Nielsen, and G.B. Munro Anti-nociception is selectively enhanced by parallel inhibition of multiple subtypes of monoamine transporters in rat models of persistent and neuropathic pain Psychopharmacology 182 2005 551 561
29. L.S. Ro, and J.M. Jacobs The role of the saphenous nerve in experimental sciatic nerve mononeuropathy produced by loose ligatures: a behavioral study Pain 52 359 1993 369
30. H. Sadeghi, V. Hajhashemi, M. Minaiyan, A. Movahedian, and A. Talebi A study on the mechanisms involving the anti-inflammatory effect of amitriptyline in carrageenan-induced paw edema in rats Eur. J. Pharmacol. 667 1-3 2011 396 401
31. S. Schreiber, M. Backer, and C. Pick The antinociceptive effect of venlafaxine in mice is mediated through opioid and adrenergic mechanisms Neurosci. Lett. 273 2 1999 85 88
32. J.E. Sumpton, and D.E. Moulin Treatment of neuropathic pain with venlafaxine Ann. Pharmacother. 35 2001 557 559
33. K. Taylor, and M.C. Rowbotham Venlafaxine hydrochloride and chronic pain West J. Med. 165 1996 147 148
34. J. Verdi, M. Jafari-Sabet, R. Mokhtari, A. Mesdaghinia, and H.R. Banafshe The effect of progesterone on expression and development of neuropathic pain in a rat model of peripheral neuropathy Eur. J. Pharmacol. 699 1-3 2013 207 212
35. P.D. Wall, and R. Melzack Textbook of Pain fourth ed. 1999 815 851
36. M. Zimmermann Pathobiology of neuropathic pain Eur. J. Pharmacol. 429 2001 23 37